MetLife, 5.875% Senior Notes due 11/21/2033 (MLG)

Free Cash Flow

$16.57B

TTM · Period ending: · USD

MLG logo

MLG Free Cash Flow

Latest reported$16.57B
MLG TTM Free Cash Flow ($3.88B → $16.57B)
High-resolution chart · PNG

MLG free cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

MetLife, 5.875% Senior Notes due 11/21/2033 Free Cash Flow — Trailing twelve months (TTM) (USD)
Period endingFree Cash Flow (USD)
16,571,000,000
16,530,000,000
18,105,000,000
15,145,000,000
15,747,000,000
17,050,000,000
15,116,000,000
15,708,000,000
15,014,000,000
14,562,000,000
14,260,000,000
9,169,000,000
10,004,000,000
11,359,000,000
11,373,000,000
16,314,000,000
15,510,000,000
13,371,000,000
12,827,000,000
12,278,000,000
12,565,000,000
11,157,000,000
11,508,000,000
11,806,000,000
12,159,000,000
13,700,000,000
13,925,000,000
7,694,000,000
7,081,000,000
10,302,000,000
9,526,000,000
12,923,000,000
14,124,000,000
11,917,000,000
12,719,000,000
15,766,000,000
13,960,000,000
14,850,000,000
14,665,000,000
13,734,000,000
13,445,000,000
13,356,000,000
14,129,000,000
14,953,000,000
16,343,000,000
16,578,000,000
16,376,000,000
17,097,000,000
15,738,000,000
15,882,000,000
16,131,000,000
11,856,000,000
12,372,000,000
12,815,000,000
15,840,000,000
17,492,000,000
16,552,000,000
13,467,000,000
11,208,000,000
9,239,000,000
9,977,000,000
8,966,000,000
8,162,000,000
7,905,000,000
8,987,000,000
7,778,000,000
3,924,000,000
6,439,000,000
3,641,000,000
5,462,000,000
10,211,000,000
663,000,000
2,176,000,000
2,963,000,000
1,187,000,000
7,646,000,000
6,728,000,000
6,108,000,000
6,600,000,000
9,059,000,000
8,413,000,000
9,181,000,000
8,853,000,000
8,482,000,000
8,130,000,000
7,919,000,000
7,057,000,000
6,565,000,000
7,161,000,000
7,182,000,000
7,042,000,000
7,179,000,000
6,663,000,000
5,395,000,000
4,997,000,000
4,318,000,000
3,955,000,000
3,851,000,000
4,799,000,000
2,306,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.